Century Therapeutics Executives Sell Shares Amid Market Volatility.

Century Therapeutics, Inc. has announced that its Senior Vice President of Finance and Operations, Carr Douglas, has sold 247 shares at a price of $2.54 per share on March 9, 2026. Additionally, the company's Chief Technology and Manufacturing Officer, Gregory Russotti, has sold 479 shares at the same price on the same date.